JP2024527138A - 様々な血清型のストレプトコッカス・スイスに対して保護するためのワクチン - Google Patents

様々な血清型のストレプトコッカス・スイスに対して保護するためのワクチン Download PDF

Info

Publication number
JP2024527138A
JP2024527138A JP2024506499A JP2024506499A JP2024527138A JP 2024527138 A JP2024527138 A JP 2024527138A JP 2024506499 A JP2024506499 A JP 2024506499A JP 2024506499 A JP2024506499 A JP 2024506499A JP 2024527138 A JP2024527138 A JP 2024527138A
Authority
JP
Japan
Prior art keywords
serotype
streptococcus suis
igm protease
suis
igm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024506499A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024527138A5 (cg-RX-API-DMAC7.html
Inventor
ジェイコブス,アントニウス・アーノルドゥス・クリスチャン
Original Assignee
インターベット インターナショナル ベー. フェー.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by インターベット インターナショナル ベー. フェー. filed Critical インターベット インターナショナル ベー. フェー.
Publication of JP2024527138A publication Critical patent/JP2024527138A/ja
Publication of JP2024527138A5 publication Critical patent/JP2024527138A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2024506499A 2021-08-03 2022-06-29 様々な血清型のストレプトコッカス・スイスに対して保護するためのワクチン Pending JP2024527138A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21189277.3 2021-08-03
EP21189277 2021-08-03
PCT/EP2022/067890 WO2023011810A1 (en) 2021-08-03 2022-06-29 A vaccine for protection against streptococcus suis of various serotypes

Publications (2)

Publication Number Publication Date
JP2024527138A true JP2024527138A (ja) 2024-07-19
JP2024527138A5 JP2024527138A5 (cg-RX-API-DMAC7.html) 2025-07-03

Family

ID=77206928

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024506499A Pending JP2024527138A (ja) 2021-08-03 2022-06-29 様々な血清型のストレプトコッカス・スイスに対して保護するためのワクチン

Country Status (5)

Country Link
US (1) US20240335520A1 (cg-RX-API-DMAC7.html)
EP (1) EP4380610A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024527138A (cg-RX-API-DMAC7.html)
CN (1) CN117794564A (cg-RX-API-DMAC7.html)
WO (1) WO2023011810A1 (cg-RX-API-DMAC7.html)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012521391A (ja) * 2009-03-26 2012-09-13 インターベツト・インターナシヨナル・ベー・ベー 各種血清型のブタ連鎖球菌(Streptococcussuis)細菌から防御するためのワクチン
JP2017518367A (ja) * 2014-05-30 2017-07-06 イーデーテー ビオロギカ ゲーエムベーハーIdt Biologika Gmbh ストレプトコッカス・スイス感染に対するワクチン組成物
JP2023517684A (ja) * 2020-03-14 2023-04-26 インターベット インターナショナル ベー. フェー. ストレプトコッカス・スイス血清型9、配列型16に対する防御のためのワクチン

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7572457B2 (en) * 2006-03-31 2009-08-11 Wisconsin Alumni Research Foundation Use of Streptococcus suis 38 kDa polypeptide as an immunogen
WO2013033092A2 (en) * 2011-09-03 2013-03-07 Boehringer Ingelheim Vetmedica Gmbh Streptococcus suis pilus antigens
WO2015181835A1 (en) 2014-05-30 2015-12-03 Naresh Laxminarayan Grover Mobile device with biometric, extra gps and alcohol sensor
US11155585B2 (en) 2015-07-09 2021-10-26 Intervacc Ab Vaccine against S. suis infection
EP3359188A1 (en) * 2015-10-07 2018-08-15 Boehringer Ingelheim Vetmedica, Inc. Streptococcus suis polysaccharide-protein conjugate composition
CN111447945A (zh) 2017-12-15 2020-07-24 英特维特国际股份有限公司 用于保护以抗猪链球菌的疫苗
ES3061725T3 (en) 2018-04-03 2026-04-07 Intervet Int Bv A vaccine for protection against streptococcus suis
WO2020094762A1 (en) 2018-11-08 2020-05-14 Intervet International B.V. A vaccine for protection against streptococcus suis
CN112402602A (zh) * 2020-11-09 2021-02-26 山东滨州沃华生物工程有限公司 一种四价猪链球菌病灭活疫苗佐剂、灭活疫苗及制备方法
US20240325514A1 (en) * 2021-08-03 2024-10-03 Intervet Inc. A vaccine for protection against streptococcus suis of various serotypes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012521391A (ja) * 2009-03-26 2012-09-13 インターベツト・インターナシヨナル・ベー・ベー 各種血清型のブタ連鎖球菌(Streptococcussuis)細菌から防御するためのワクチン
JP2017518367A (ja) * 2014-05-30 2017-07-06 イーデーテー ビオロギカ ゲーエムベーハーIdt Biologika Gmbh ストレプトコッカス・スイス感染に対するワクチン組成物
JP2023517684A (ja) * 2020-03-14 2023-04-26 インターベット インターナショナル ベー. フェー. ストレプトコッカス・スイス血清型9、配列型16に対する防御のためのワクチン

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
VACCINE, 2015,, vol. 33, no. 19, JPN6026025330, 2015, pages 2207 - 2212, ISSN: 0005892123 *
VETERINARY IMMUNOLOGY AND IMMUNOPATKOLOGY, vol. 146, no. 3, JPN6026025329, 2012, pages 191 - 200, ISSN: 0005892124 *

Also Published As

Publication number Publication date
US20240335520A1 (en) 2024-10-10
WO2023011810A1 (en) 2023-02-09
EP4380610A1 (en) 2024-06-12
CN117794564A (zh) 2024-03-29

Similar Documents

Publication Publication Date Title
US11103569B2 (en) Vaccine for protection against Streptococcus suis
JP7571015B2 (ja) 豚レンサ球菌感染防御のためのワクチン
JP7728784B2 (ja) ストレプトコッカス・スイス血清型9、配列型16に対する防御のためのワクチン
EP4380612A1 (en) A vaccine for protection against streptococcus suis of various serotypes
JP7295223B2 (ja) 混合ワクチン
EP4380611A1 (en) A vaccine for protection against streptococcus suis of various serotypes
KR102819995B1 (ko) 연쇄상구균에 대한 보호를 위한 백신
RU2841376C1 (ru) Вакцина для защиты от streptococcus suis серотипа 9, тип последовательности 16
EP4380610A1 (en) A vaccine for protection against streptococcus suis of various serotypes
RU2777065C1 (ru) Комбинированная вакцина
RU2802072C2 (ru) Вакцина для защиты от streptococcus suis
WO2025040792A1 (en) Multivalent vaccine against swine infections
WO2025040802A1 (en) New scheme of administration of a multivalent vaccine against swine infections

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250625

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250625

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260615

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260623